Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease (2012)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1159/000336108
- Subjects: BIOMARCADORES; INSUFICIÊNCIA RENAL CRÔNICA; METALOPROTEINASES; POLIMORFISMO; ESTUDOS DE CASOS E CONTROLES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Journal of Nephrology
- ISSN: 0250-8095
- Volume/Número/Paginação/Ano: v. 35, n. 3, p. 209-215, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
MARSON, Bernardo P. et al. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, v. 35, n. 3, p. 209-215, 2012Tradução . . Disponível em: https://doi.org/10.1159/000336108. Acesso em: 18 abr. 2024. -
APA
Marson, B. P., Lacchini, R., Belo, V., Dickel, S., Costa, B. P. da, Figueiredo, C. E. P. de, & Tanus-Santos, J. E. (2012). Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease. American Journal of Nephrology, 35( 3), 209-215. doi:10.1159/000336108 -
NLM
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1159/000336108 -
Vancouver
Marson BP, Lacchini R, Belo V, Dickel S, Costa BP da, Figueiredo CEP de, Tanus-Santos JE. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease [Internet]. American Journal of Nephrology. 2012 ; 35( 3): 209-215.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1159/000336108 - Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endotélio e genética
- Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects
- Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population
- Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels
- Pharmacogenetics of erectile dysfunction: navigating into uncharted waters
Informações sobre o DOI: 10.1159/000336108 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
